Skip to main content
. 2020 Feb 12;9(2):420. doi: 10.3390/cells9020420

Table 2.

Advantages and disadvantages of the discussed current approaches used for liver therapy and regeneration.

Advantages Disadvantages
Orthotopic Liver Transplantation (OLT) 88% patient survival
Clinically defined
Shortage of donors
Post-surgery complications
Life-long immunosuppressive treatment
Organ rejection
Artificial Liver (AL) Device Detoxification ability
Bridge patients to OLT
Selective removal/detoxification of toxins
Ineffective against encephalopathy
Temporary support device
Cell Transplantation Surgical procedure safer and less invasive than OLT
Partial correction of liver metabolic disorders
Shortage of cells
Transitory improvement of patients’ conditions
Bio Artificial Liver (BAL) Device Improved detoxification ability due to biological components
Bridge patients to OLT
Shortage of cells
Clinical trials suspended or incomplete
Complex set-up and scale-up
Decellularized/Cellularized Liver Scaffolds
(Pre-Clinical Development)
Improvement of hepatic cells functions with respect to classic scaffold-based culture approaches
Liver-like tissue bio-construction transplantable
Shortage of cells
Partial cell repopulation of the scaffolds
Slow maturation of the construct
Poor viability in pre-clinical studies
Liver Biofabrication and Bioprinting
(Pre-Clinical Development)
Easy scale-up of the 3D liver constructs
Improvement of hepatic cell maturations with respect to 3D classic culture approaches
Shortage of cells
Slow maturation of the construct
Contradictory published data on construct viability